Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
The Lancet. Respiratory Medicine|May 8, 2021
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective studyXiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.Frontiers in Oncology|December 12, 2024
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancerHuilin Cui, Qianqian Yu, Qumiao Xu, et al.Genome Medicine|January 19, 2024
Gut microbiome for predicting immune checkpoint blockade-associated adverse eventsMuni Hu, Xiaolin Lin, Tiantian Sun, et al.Cell Metabolism|February 20, 2025
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's diseaseZhenyu Wang, Li Tian, Yi Jiang, et al.Cell Host & Microbe|March 21, 2024
A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapyXiaoqiang Zhu, Xiaowen Huang, Muni Hu, et al.Cell Host & Microbe|November 9, 2023
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohortsXiaowen Huang, Muni Hu, Tiantian Sun, et al.Cell Metabolism|January 22, 2026
Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacyTianying Tong, Xiaowen Huang, Lingxi Li, et al.The Journal of Biological Chemistry|August 21, 2021
Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosisLiudi Yao, Yilu Zhou, Juanjuan Li, et al.Cell Host & Microbe|May 28, 2026
Cross-kingdom metabolic interactions govern Candida albicans overgrowth and colitis progressionYilu Zhou, Jinmei Ding, Lijun Ning, et al.Cell Death & Disease|August 9, 2019
Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosisCharlotte Hill, Juanjuan Li, Dian Liu, et al.Pageof 8